Akzo Nobel N.V.

The Axalta acquisition significantly expands Akzo Nobel's scale and product portfolio in coatings, with the merger consideration per Axalta share rising from approximately $30.25 to $34.36 between November 2025 and June 2026, suggesting growing confidence in the deal's strategic value.

The fairness of the all-stock exchange ratio (0.6539 Akzo Nobel shares per Axalta share) is under active investigation, raising concerns that Axalta shareholders may not receive fair value and that the deal could dilute Akzo Nobel's existing shareholders or strain its balance sheet.

Akzo Nobel's repeated rejection of acquisition approaches from Nippon Paint signals management's confidence in the company's standalone strategy and intrinsic value, suggesting the board believes current market pricing undervalues the business and that independence better serves long-term shareholders.

Repeated unsolicited acquisition attempts by Nippon Paint highlight ongoing governance concerns and questions about whether management is acting in shareholders' best interests by rejecting offers, potentially leaving value on the table amid a muted 2026 earnings outlook.

Consensus analyst estimates project earnings per share growth of approximately 15% for the coming year, rising from $1.46 to $1.68, supported by a majority Buy consensus among 16 analysts and an average 12-month price target of €63.69, representing over 10% upside from current levels.

Bernstein downgraded Akzo Nobel to Market Perform citing a muted 2026 outlook, while Jefferies maintains a Hold with a price target of €55 — below the current share price — reflecting concern that Q4 results missed estimates and that near-term earnings momentum remains insufficient to justify a premium valuation.